Promoter to IL-18BP, its preparation and use

Details Promoter to IL-18BP, its preparation and use Promoter to IL-18BP, its preparation and use

2011-01-11

2011-01-11

Marvich, Maria (Department: 1633)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C435S320100, C435S069100, C435S325000

Reexamination Certificate

active

07868154

ABSTRACT:
The present invention relates to the promoter of interleukin-18 binding protein (IL-18BP), to its preparation and use.

REFERENCES:
patent: 4966843 (1990-10-01), McCormick et al.
patent: 0 546 333 (1993-06-01), None
patent: WO 99 09063 (1999-02-01), None
Osoegawa et al. (2001) Genome Res. 11:483-496.
Guan et al. (1995) J. Biol. Chem. 270:21958-21965.
Entrez Nucleotide Database entry for Accession No. AP000719, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=13094220, sequence published prior to Jul. 23, 2002.
Entrez Nucleotide Database entry for Accession No. AF110798, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=4324923, published Mar. 3, 1999, downloaded Oct. 29, 2007.
Rubanyi (2001) Mol. Aspects Med. 22:113-142.
Ross et al. (1996) Human gene Therapy 7:1781-1790.
Eck et al. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Edition, Chapter 5, McGraw-Hill, NY.
Marshall (1995) Science 269:1050-1055.
Verma et al. (1997) Nature 389:239-242.
Pance et al, A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation, FASEB J. (Feb. 25, 2002), pp. 631-633.
Novick, D. et al. Interleukin-18 Binding Protein: A Novel Modulator of the TH1 Cytokine Response; Immunity,Cell Press, US, Online!,vol. 10, No. 1, Jan. 1999, pp. 127-136.
Kim, S-H et al. Structural Requirements of Six Naturally Occurring Isoforms of the IL-18 Binding Protein to Inhibit IL-18,Proceedings of the National Academy of Sciences of USA, National Academy of Science. Washington, US, vol. 97, No. 3, Feb. 1, 2000, pp. 1190-1195.
Database EMBL ′Online! Nov. 4, 2002 Novick: “IL18 binding protein” retrieved from EBI Database accession No. BD074754.
Database EMBL ′Online! Nov. 4, 2002 Novick: “IL18 binding protein” retrieved from EBI Database accession No. BD074752.
Hurgin, Vladimir et al. The promoter of IL-18 binding protein: Activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enchancer binding protein beta.Proceedings of the National Academy of Sciences of the United States, vol. 99, No. 26, Dec. 24, 2002, pp. 16957-16962.
Hurgin, Vladimir et al. Transcriptional regulation of IL-18 binding protein gene expression,Journal of Interferon and Cytokine Research, vol. 24, No. Supplement 1, 2001, p. S.73.
Banner I, et al. “Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.” J Virol. Jun. 1993;67(6):3199-207.
Boshart M, et al. “A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.” Cell. Jun. 1985;41(2):521-30.
Bregni M, et al. “Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.” Blood. Sep. 15, 1992;80(6):1418-22.
Brinster Rl, et al. “Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs.” Cell. Nov. 1981;27(1 Pt 2):223-31.
Cassel A, et al. “Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells.” Exp Hematol. Apr. 1993;21(4):585-91.
Chao NJ, et al. “Granulocyte colony-stimulating factor “mobilized” peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.” Blood. Apr. 15, 1993;81(8):2031-5.
Chen JD, et al. “Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy.” Nature Med. Oct. 1997;3(10):1110-6.
Costantini F, and Lacy E. “Introduction of a rabbit beta-globin gene into the mouse germ line.” Nature. Nov. 5, 1981;294:92-4.
Couture LA, and Stinchcomb DT. “Anti-gene therapy: the use of ribozymes to inhibit gene function.” Trends Genet. Dec. 1996;12(12):510-5.
Dignam JD, et al. “Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.” Nucleic Acids Res. Mar. 11, 1983;11(5):1475-89.
Dijkema R, et al. “Cloning and expression of the chromosomal immune interferon gene of the rat.” EMBO J. Mar. 1985;4(3):761-7.
Dunbar CE, et al. “Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.” Blood. Jun. 1, 1995;85(11):3048-57.
Dynan WS, and Tjian R. “Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins.” Nature. Aug. 29-Sep. 4, 1985;316(6031):774-8.
Dynan WS. “Modularity in promoters and enhancers.” Cell. 1989 Jul. 14;58(1):1-4.
Fletcher C, et al. “Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene.” Cell. Dec. 4, 1987;51(5)773-81.
Fried M, and Crothers DM. “Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.” Nucleic Acids Res. Dec. 11, 1981;9(23):6505-25.
Gale RP, et al. “Blood stem cell transplants come of age.” Bone Marrow Transplant. Mar. 1992;9(3):151-5.
Gordon S, and Werb Z. “Secretion of macrophage neutral proteinase is enhanced by colchicine.” Proc Natl Acad Sci U S A. Mar. 1976;73(3):872-6.
Gorman CM, et al. “The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.” Proc Natl Acad Sci U S A. Nov. 1982;79(22):6777-81.
Hao QL, et al. “A functional comparison of CD34 + CD38- cells in cord blood and bone marrow.” Blood. Nov. 15, 1995;86(10):3745-53.
Harbers K, et al. “Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal.” Nature. Oct. 15, 1981;293:540-2.
Henon PR, et al. “Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants.” Bone Marrow Transplant. Apr. 1992;9(4):285-91.
Herzog RW, et al. “Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.” Proc Natl Acad Sci U S A. May 27, 1997;27;94(11):5804-9.
Junker U, et al. “Hematopoietic potential and retroviral transduction of CD34+ Thy-1+ peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor.” Blood. Jun. 15, 1997;89(12):4299-306.
Kearns WG, et al. “Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.” Gene Ther. Sep. 1996;3(9):748-55.
Kohn DB, et al. “A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children.” Blood. Jul. 1, 1999;94(1):368-71.
Lee SW, et al. “Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.” J Virol. Dec. 1994;68(12):8254-64.
Lotti F, et al. “Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.” J Virol. Apr. 2002;76(8):3996-4007.
Malim MH, et al. “Functional dissection of the HIV-1 Rev trans-activator—derivation of a trans-dominant repressor of Rev function.” Cell. Jul. 14, 1989;58(1)205-14.
Maniatis T, et al. “Regulation of inducible and tissue-specific gene expression.” Science. Jun. 5, 1987;236:1237-45.
Marasco WA. “Intrabodies: turning the humoral immune system outside in for intracellular immunization.” Gene Ther. Jan. 1997;4(1):11-5.
Mcknight S, and Tjian R. “Transcriptional selectivity of viral genes in mammalian cells.” Cell. Sep. 12, 1986;46 (6):79

Affiliated with

Also associated with

Rating

Promoter to IL-18BP, its preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Promoter to IL-18BP, its preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promoter to IL-18BP, its preparation and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2718722